[{"address1": "5 Nahum Heftsadie Street", "address2": "Givaat Shaul PO Box 34670", "city": "Jerusalem", "zip": "91340", "country": "Israel", "phone": "972 2 659 5666", "fax": "972 2 659 5616", "website": "https://www.gamida-cell.com", "industry": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Gamida Cell Ltd., a clinical-stage biopharmaceutical company, develops cell therapies to cure blood cancers and serious blood diseases. The company's lead product candidate is omidubicel, a cell therapy that has completed Phase III clinical trial in patients with hematologic malignancies, as well as in Phase II clinical trials in patients with severe aplastic anemia. It is also developing GDA-201, an investigational NK cell-based cancer immunotherapy, which is in Phase I/II studies for the treatment of relapsed or refractory non-Hodgkin lymphoma and multiple myeloma. The company was incorporated in 1998 and is headquartered in Jerusalem, Israel.", "fullTimeEmployees": 143, "companyOfficers": [{"maxAge": 1, "name": "Ms. Abigail L. Jenkins", "age": 47, "title": "President, CEO & Director", "yearBorn": 1976, "fiscalYear": 2022, "totalPay": 554053, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Michele Ilene Korfin M.B.A., R.Ph.", "age": 51, "title": "Chief Operating & Chief Commercial Officer", "yearBorn": 1972, "fiscalYear": 2022, "totalPay": 606000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Ronit  Simantov M.D.", "age": 58, "title": "Chief Medical Officer & Chief Scientific Officer", "yearBorn": 1965, "fiscalYear": 2022, "totalPay": 592000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Joshua F. Patterson", "age": 46, "title": "General Counsel & Chief Compliance Officer", "yearBorn": 1977, "fiscalYear": 2022, "totalPay": 479000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Mary Theresa Coelho M.B.A.", "age": 60, "title": "CFO, Principal Financial Officer & Principal Accounting Officer", "yearBorn": 1963, "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Linda  Stamler", "title": "Vice President of Marketing & Account Management", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Penny  Bushell", "title": "Chief Human Resource Officer", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Naftali  Brikashvili CPA", "title": "Senior Vice President Finance & Operations", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Tracey  Lodie Ph.D.", "age": 53, "title": "Scientific Advisor & Consultant", "yearBorn": 1970, "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Vladimir  Melnikov", "title": "Senior Vice President of Global Operations & Manufacturing", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400, "priceHint": 4, "previousClose": 0.0327, "open": 0.0395, "dayLow": 0.0327, "dayHigh": 0.0327, "regularMarketPreviousClose": 0.0327, "regularMarketOpen": 0.0395, "regularMarketDayLow": 0.0327, "regularMarketDayHigh": 0.0327, "beta": 1.032, "forwardPE": -0.058392853, "volume": 23036893, "regularMarketVolume": 23036893, "averageVolume": 9670277, "averageVolume10days": 4411302, "averageDailyVolume10Day": 4411302, "marketCap": 4337295, "fiftyTwoWeekLow": 0.008, "fiftyTwoWeekHigh": 2.51, "priceToSalesTrailing12Months": 6.444718, "fiftyDayAverage": 0.242678, "twoHundredDayAverage": 0.6279255, "currency": "USD", "enterpriseValue": 70282008, "floatShares": 120376083, "sharesOutstanding": 132639000, "sharesShort": 9984910, "sharesShortPriorMonth": 8860512, "sharesShortPreviousMonthDate": 1706659200, "dateShortInterest": 1709164800, "sharesPercentSharesOut": 0.0753, "heldPercentInsiders": 0.11578, "heldPercentInstitutions": 0.26489002, "shortRatio": 3.51, "shortPercentOfFloat": 0.079, "bookValue": 0.003, "priceToBook": 10.9, "lastFiscalYearEnd": 1672444800, "nextFiscalYearEnd": 1703980800, "mostRecentQuarter": 1696032000, "netIncomeToCommon": -76951000, "trailingEps": -0.82, "forwardEps": -0.56, "enterpriseToRevenue": 104.431, "enterpriseToEbitda": -0.926, "exchange": "NGM", "quoteType": "EQUITY", "symbol": "GMDA", "underlyingSymbol": "GMDA", "shortName": "Gamida Cell Ltd.", "longName": "Gamida Cell Ltd.", "firstTradeDateEpochUtc": 1540560600, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "ff39c3c4-fc7a-3cce-8fdf-d4071894393b", "gmtOffSetMilliseconds": -14400000, "currentPrice": 0.0327, "targetHighPrice": 6.0, "targetLowPrice": 2.0, "targetMeanPrice": 4.0, "targetMedianPrice": 4.0, "recommendationMean": 2.3, "recommendationKey": "buy", "numberOfAnalystOpinions": 2, "totalCash": 60431000, "totalCashPerShare": 0.456, "ebitda": -75910000, "totalDebt": 85218000, "quickRatio": 2.959, "currentRatio": 3.317, "totalRevenue": 673000, "debtToEquity": 22308.377, "revenuePerShare": 0.007, "returnOnAssets": -0.41467, "returnOnEquity": -11.037939, "freeCashflow": -54192376, "operatingCashflow": -79035000, "grossMargins": 0.06984, "operatingMargins": -26.80238, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-06-18"}]